Cleared Traditional

K993101 - LITEAIRE

K993101 is an FDA 510(k) clearance for LITEAIRE, manufactured by Thayer Medical Corp.. The device is a Class 2 Anesthesiology device with product code CAF cleared through the Traditional 510(k) pathway after a 406-day FDA review.

K993101 · Thayer Medical Corp. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2000
Decision
406d
Days
Class 2
Risk

K993101 is an FDA 510(k) clearance for the LITEAIRE. Classified as Nebulizer (direct Patient Interface) (product code CAF), Class II - Special Controls.

Submitted by Thayer Medical Corp. (Tucson, US). The FDA issued a Cleared decision on October 26, 2000 after a review of 406 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5630 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Anesthesiology submissions.

FDA 510(k) Submission Details - K993101

510(k) Number K993101 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 16, 1999
Decision Date October 26, 2000
Days to Decision 406 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
266d slower than avg
Panel avg: 140d · This submission: 406d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAF Device Classification - Class 2, Special Controls

Product Code CAF Nebulizer (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAF Nebulizer (direct Patient Interface)

All 441
Devices cleared under the same product code (CAF) and FDA review panel - the closest regulatory comparables to K993101.
CT SPACER
K010680 · Clinical Technologies, Inc. · May 2001
MEDICAL DEPOT NEBULIZER, MODEL POWER NEB 2
K003344 · Medical Depot, Inc. · Mar 2001
ULTRASONIC NEBULIZER, MODEL NE-520
K002153 · Medisana USA, Inc. · Mar 2001
AERONEB PORTABLE NEBULIZER
K003022 · Aerogen, Inc. · Oct 2000
AERONEB II, MODEL APN 200
K992831 · Aerogen, Inc. · Aug 2000
AEROTRACH PLUS VALVED HOLDING CHAMBER (VHC)
K001137 · Trudell Medical Int'L · Jul 2000